{"version":"1.0","type":"link","title":"Risk Factors for the Exacerbation of Esophageal Varices in Patients Receiving Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma.","author_name":"Takada H 외","author_url":"https://prs-insight.online/author/Takada%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/118702","thumbnail_width":1200,"thumbnail_height":630}